Evidence receipt / belief
Published · transcript-backedBen Gilbert: belief
22 Jan 2024 Acquired Novo Nordisk (Ozempic)
“I think that the most illustrative stats on this are that the top decile of pharmaceuticals are what matters for the profits.”
Source trail
Everything needed to verify it.
- Speaker
- Ben Gilbert
- Attribution
- Verified speaker
- Claim type
- belief
- Recorded
- 22 Jan 2024
- Publisher
- Acquired
- Episode
- Novo Nordisk (Ozempic)
Transcript context
…Four years, that's nothing. Yeah. There's no MVP in Semaglutide. Let's put a couple billion to work, and then we'll check in a couple decades later and see if we've changed the world. Obviously, there are stage gates along the way, but it's adding a zero or two to the venture business, to be honest. I think that the most illustrative stats on this are that the top decile of pharmaceuticals are what matters for the profits. If you look at the pipeline of a hundred drugs that enter clinical development, ten actually make it to market, and one provides half the profits, one drug. Oh, crap. Wow. The initial part of what you just said jives with our math earlier that 10% make it to market. That's a power law right there.…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.